Glavine Paul purchased $1.2M of HELP
Glavine Paul (Chief Growth Officer) purchased 100,000 shares of CYBIN INC. (HELP) at $12.47 ($1.25M total) on 2026-09-08.
How this was made
The 30-second read
Why it matters
The purchase adds to insider confidence metrics, often used by traders to gauge sentiment.
Market read
Insider buying of $1.2M is a notable event for HELP, offering a modest bullish cue for traders.
What to watch
Potential upcoming clinical data or partnership not disclosed could be driving the purchase.
Background
SEC Form 4 filing discloses insider transactions; such filings are primary sources of material information.
Ticker impact
Chief Growth Officer Glavine Paul purchased 100,000 shares of CYBIN Inc. for $1.247M, increasing his stake to over 4.2M shares.
Potential modest price appreciation in the next few trading sessions.
Insider acquisition of $1.2M is material for a micro‑cap, indicating strong internal belief in valuation; however, the amount is not large enough to drive a major move alone.
Market effects
May signal confidence in the biotech/health‑tech sector, but impact is limited to CYBIN.
Primarily U.S. market; negligible regional effect.
Low global relevance; confined to the stock.
Counterpoint
Insider buying could be a routine portfolio rebalancing rather than a bullish signal.
Key entities
- companyCYBIN Inc.
Biotech firm listed on NASDAQ under ticker HELP.
- personGlavine Paul
Chief Growth Officer of CYBIN Inc.